Page last updated: 2024-12-04

dimethylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimethylglycine: metabolic product of calcium pangamate; mutagen when mixed with nitrite; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N,N-dimethylglycine : An N-methylglycine that is glycine carrying two N-methyl substituents. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
GlycinegenusA non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID673
CHEMBL ID1232274
CHEBI ID17724
SCHEMBL ID21778
SCHEMBL ID8125857
MeSH IDM0084155

Synonyms (71)

Synonym
CHEMBL1232274
CHEBI:17724 ,
(dimethylamino)acetic acid
n,n-dimethylaminoacetic acid
n-methylsarcosine
2-(dimethylamino)acetic acid
brn 1700261
einecs 214-267-8
glycine, n,n-dimethyl-
inchi=1/c4h9no2/c1-5(2)3-4(6)7/h3h2,1-2h3,(h,6,7
C01026
1118-68-9
dimethylglycine
n,n-dimethylglycine
n,n-dimethylglycine, >=99%
DB02083
3C95768C-C28C-4AF9-A119-01AC8F0B963B
D3585
BMSE000241
2-(dimethylammonio)acetate
A802428
AKOS003590893
STL138371
EN300-66975
4-04-00-02365 (beilstein handbook reference)
n,n-dimethyl glycine
7797m4cppa ,
unii-7797m4cppa
BP-10272
FT-0629542
AM20080064
n,n-dimethylglycine [mi]
n,n-dimethylglycine [who-dd]
S6056
dimethyl glycine
n,n dimethylglycine
n,n-dimethylglycin
n,n dimethyl glycine
n,n,-dimethylglycine
dimethylamino acetic acid
n,n-dimethyl-glycine
dimethylamino-acetic acid
n, n-dimethyl glycine
n,n-dimethyglycine
dimethylaminoacetic acid
n,-n-dimethyl glycine
2-dimethylaminoacetic acid
n, n-dimethylglycine
SCHEMBL21778
mfcd00004283
SY001194
SCHEMBL8125857
(dimethylamino)acetic acid #
Q-201431
STR05828
780741-89-1
DTXSID6074336
Z235580496
n,n-dimethylglycine, for hplc derivatization, >=99% (nt)
n,n-dimethylglycine, puriss., >=99.0% (nt)
CS-D1391
n-methylsarcosine n,n-dimethyl-glycine
n,n-dimethylaminoacetate
2-(dimethylamino)acetate
(dimethylamino)acetate
HY-Y0511
Q4369
NCGC00532505-01
dimethylglycine powder
2-(dimethylamino)aceticacid
n,n-dimthylglycine

Research Excerpts

Overview

N,N-dimethylglycine (DMG) is a naturally occurring compound being widely used as an oral supplement to improve growth and physical performance. Dimethyl glycine is a product of the choline oxidation pathway and formed from betaine during folate-independent remethylation of homocysteine (Hcy) to methionine.

ExcerptReferenceRelevance
"N,N-dimethylglycine (DMG) is a naturally occurring compound being widely used as an oral supplement to improve growth and physical performance. "( N,N-Dimethylglycine Sodium Salt Exerts Marked Anti-Inflammatory Effects in Various Dermatitis Models and Activates Human Epidermal Keratinocytes by Increasing Proliferation, Migration, and Growth Factor Release.
Bácsi, A; Becker, M; Béke, G; Bíró, T; Hollósi, E; Lendvai, A; Mihály, J; Schulze Zur Wiesche, E; Völker, JM, 2023
)
2.03
"N, N-dimethylglycine (DMG) is a nutrient supplement and acts as an NMDAR glycine site partial agonist."( N, N-dimethylglycine Protects Behavioral Disturbances and Synaptic Deficits Induced by Repeated Ketamine Exposure in Mice.
Chan, MH; Chen, HH; Chen, ST; Hsieh, CP; Huang, CM; Lee, MY, 2021
)
1.59
"Dimethylglycine (DMG) is a product of the choline oxidation pathway and formed from betaine during the folate-independent remethylation of homocysteine (Hcy) to methionine. "( Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study.
Apalset, EM; Gjesdal, CG; Lysne, V; Meyer, K; Nygård, OK; Svingen, GF; Tell, GS; Ueland, PM; Vollset, SE; Øyen, J, 2015
)
2.31
"N,N-dimethylglycine (DMG) is a derivative of the amino acid glycine and is used as a dietary supplement."( N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
Chan, MH; Chen, HH; Chen, YC; Lee, MY; Lin, JC, 2016
)
1.47
"N,N-dimethylglycine (DMG) is an intermediary metabolite in cellular choline and betaine metabolism. "( Dietary N,N-dimethylglycine supplementation improves nutrient digestibility and attenuates pulmonary hypertension syndrome in broilers.
Buyse, J; Cools, A; Janssens, GP; Kalmar, ID; Roose, P, 2010
)
1.3
"N,N-Dimethylglycine (DMG) is a tertiary amino acid that naturally occurs as an intermediate metabolite in choline-to-glycine metabolism. "( Tolerance and safety evaluation of N,N-dimethylglycine, a naturally occurring organic compound, as a feed additive in broiler diets.
Janssens, GP; Kalmar, ID; Maenner, K; Meulemans, G; Verstegen, MW; Zentek, J, 2012
)
1.21
"Dimethylglycine is an anti-stress nutrient with antioxidant properties. "( Effect of dimethylglycine on gastric ulcers in rats.
Hariganesh, K; Prathiba, J, 2000
)
2.15

Actions

ExcerptReferenceRelevance
"Dimethylglycine did not produce any significant change in acid secretion, unlike famotidine."( Effect of dimethylglycine on gastric ulcers in rats.
Hariganesh, K; Prathiba, J, 2000
)
1.43

Toxicity

ExcerptReferenceRelevance
"Levocarnitine treatment is usually well tolerated, with essentially dose-dependent diarrhea as the main induced adverse effect."( [L-carnitine treatment and fish odor syndrome: an unwaited adverse effect].
Broly, F; Caruba, C; Lebrun, C; Rocher, F,
)
0.13
"This adverse effect seems to be correlated with excedent carnitine intake and might be expressed when the elimination pathway becomes saturated or in a situation of deficiency enzymatic metabolism."( [L-carnitine treatment and fish odor syndrome: an unwaited adverse effect].
Broly, F; Caruba, C; Lebrun, C; Rocher, F,
)
0.13

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic characteristics and metabolism of betaine in humans have not been assessed and drug monitoring for betaine therapy is not available."( Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria.
Balkenhol, N; Hafner, D; Hohlfeld, T; Laryea, MD; Schwahn, BC; Wendel, U, 2003
)
0.32
" Elimination half-life increased during continuous dosing over 5 days."( Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria.
Balkenhol, N; Hafner, D; Hohlfeld, T; Laryea, MD; Schwahn, BC; Wendel, U, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" Dosage was 300 mg/day for the first 14 days and then 600 mg/day."( N,N dimethylglycine and epilepsy.
Gascon, G; Patterson, B; Slotnick, H; Yearwood, K,
)
0.69
" Betaine, N,N-dimethylglycine and sarcosine were equipotent in decreasing the incidence of seizures and death, causing a 38 to 72 percent decrease in the incidence of seizures and death at a dosage of 5 mmole/kg."( Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine.
Freed, WJ, 1985
)
0.85
" The major methodologic weaknesses of the study are thought to be the low dosage of DMG and the small sample size."( A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.
Bolman, WM; Richmond, JA, 1999
)
0.54
" Elimination half-life increased during continuous dosing over 5 days."( Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria.
Balkenhol, N; Hafner, D; Hohlfeld, T; Laryea, MD; Schwahn, BC; Wendel, U, 2003
)
0.32
" Notably, adjusted (for age and sex) dose-response curves for the postmethionine increase in homocysteine or fasting homocysteine versus betaine showed that the inverse associations were most pronounced at low serum folate, an observation that was confirmed by analyses of interaction."( Betaine and folate status as cooperative determinants of plasma homocysteine in humans.
Blom, HJ; den Heijer, M; Holm, PI; Keijzer, MB; Midttun, Ø; Ueland, PM; Vollset, SE, 2005
)
0.33
" However, in selected cases, depending on the effectiveness of the interventions, dosage reductions or discontinuation of medications may be possible."( Natural approaches to epilepsy.
Gaby, AR, 2007
)
0.34
" However, to our knowledge, no dose-response studies have been conducted to evaluate the effects of pregnancy or maternal choline intake on biomarkers of choline metabolism."( Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans.
Allen, RH; Caudill, MA; Devapatla, S; Jiang, X; Malysheva, OV; Perry, CA; Pressman, E; Stabler, SP; Vermeylen, F; West, AA; Yan, J, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (4 Product(s))

Product Categories

Product CategoryProducts
Professional Supplements3
Vitamins & Supplements1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
DaVinci Laboratories Gluconic DMG -- 500 mg - 60 TabletsDaVinci LaboratoriesProfessional SupplementsN,N-Dimethylglycine2024-11-29 10:47:42
DaVinci Laboratories Gluconic DMG Liquid -- 300 mg - 2 fl ozDaVinci LaboratoriesProfessional SupplementsN,N-Dimethylglycine2024-11-29 10:47:42
Little DaVinci Kids Focus Brain Health Tasty Orange -- 90 Chewable TabletsLittle DaVinciProfessional SupplementsBetaine Anhydrous, N,N-Dimethylglycine, Folate, microcrystalline cellulose, Vitamin B6, Sorbitol, stearic acid, Vitamin B12, Vitamin B62024-11-29 10:47:42
Zahler DMG -- 500 mg - 90 Chewable TabletsZahlerVitamins & SupplementsDimethylglycine, malic acid, mannitol, stearic acid, Xylitol2024-11-29 10:47:42

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Daphnia magna metaboliteA Daphnia metabolite produced by the species Daphnia magna.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
N-methylglycinesAn N-alkylglycine that is sarcosine and derivatives of sarcosine arising by replacement of the hydrogen attached to the nitrogen by a hydrocarbyl group.
N-methyl-amino acidAn amino acid derivative in which at least one of the hydrogens of the amino group has been replaced by a methyl group.
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (28)

PathwayProteinsCompounds
Glycine and Serine Metabolism2452
Betaine Metabolism818
Methionine Metabolism1637
Cystathionine beta-Synthase Deficiency1637
Hypermethioninemia1637
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency1637
Glycine N-Methyltransferase Deficiency1637
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)1637
Methionine Adenosyltransferase Deficiency1637
Dimethylglycine Dehydrogenase Deficiency2452
Dihydropyrimidine Dehydrogenase Deficiency (DHPD)2452
Sarcosinemia2452
Non-Ketotic Hyperglycinemia2452
Hyperglycinemia, Non-Ketotic2452
Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type1637
3-Phosphoglycerate Dehydrogenase Deficiency2452
Quorum Sensing1020
S-Adenosyl-L-Methionine Cycle414
Sarcosine Oncometabolite Pathway1321
Glycine and Serine metabolism ( Glycine and Serine metabolism )3649
Methionine and Cysteine metabolism ( Methionine and Cysteine metabolism )2342
Diet-dependent trimethylamine/trimethylamine N-oxide metabolism112
One-carbon donor022
Trans-sulfuration, one-carbon metabolism and related pathways053
Methionine de novo and salvage pathway148
Biochemical pathways: part I0466
One-carbon metabolism and related pathways038
MTHFR deficiency1515

Research

Studies (194)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (9.28)18.7374
1990's16 (8.25)18.2507
2000's55 (28.35)29.6817
2010's82 (42.27)24.3611
2020's23 (11.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.21 (24.57)
Research Supply Index5.46 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index107.91 (26.88)
Search Engine Supply Index3.74 (0.95)

This Compound (39.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials36 (18.09%)5.53%
Reviews7 (3.52%)6.00%
Case Studies5 (2.51%)4.05%
Observational2 (1.01%)0.25%
Other149 (74.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]